ATE355360T1 - Milchsaüreferment das ein spezieller stamm von lactobacillus acidophilus enthältund verwendung - Google Patents
Milchsaüreferment das ein spezieller stamm von lactobacillus acidophilus enthältund verwendungInfo
- Publication number
- ATE355360T1 ATE355360T1 AT97945702T AT97945702T ATE355360T1 AT E355360 T1 ATE355360 T1 AT E355360T1 AT 97945702 T AT97945702 T AT 97945702T AT 97945702 T AT97945702 T AT 97945702T AT E355360 T1 ATE355360 T1 AT E355360T1
- Authority
- AT
- Austria
- Prior art keywords
- strain
- lactobacillus acidophilus
- lactic ferment
- special strain
- ferment containing
- Prior art date
Links
- 240000001046 Lactobacillus acidophilus Species 0.000 title abstract 3
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 title abstract 3
- 229940039695 lactobacillus acidophilus Drugs 0.000 title abstract 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- 235000013365 dairy product Nutrition 0.000 abstract 2
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 235000012000 cholesterol Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 abstract 1
- 201000009890 sinusitis Diseases 0.000 abstract 1
- 208000019206 urinary tract infection Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/23—Lactobacillus acidophilus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/853—Lactobacillus
- Y10S435/854—Lactobacillus acidophilus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Dairy Products (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3215796P | 1996-11-29 | 1996-11-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE355360T1 true ATE355360T1 (de) | 2006-03-15 |
Family
ID=21863414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97945702T ATE355360T1 (de) | 1996-11-29 | 1997-11-28 | Milchsaüreferment das ein spezieller stamm von lactobacillus acidophilus enthältund verwendung |
Country Status (8)
Country | Link |
---|---|
US (1) | US6607905B1 (de) |
EP (2) | EP0951531B1 (de) |
AT (1) | ATE355360T1 (de) |
AU (1) | AU5113798A (de) |
CA (1) | CA2271930C (de) |
DE (1) | DE69737420T2 (de) |
ES (1) | ES2283027T3 (de) |
WO (1) | WO1998023727A1 (de) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8563522B2 (en) | 1997-07-08 | 2013-10-22 | The Iams Company | Method of maintaining and/or attenuating a decline in quality of life |
DK1007625T3 (da) | 1997-08-21 | 2010-11-01 | New Zealand Dairy Board | Immunitetsforstærkede mællkesyrebakterie |
US6479051B1 (en) | 1998-12-11 | 2002-11-12 | Urex Biotex, Inc. | Oral administration of lactobacillus for the treatment and prevention of urogenital infection |
ES2155782B1 (es) * | 1999-05-07 | 2002-05-16 | Danone Sa | Utilizacion de bacterias acidolacticas pra preparar leches fermentadas para el tratamiento de niveles de actividad inmunitaria transitoriamente reducidos. |
ES2155783B1 (es) * | 1999-05-07 | 2002-05-16 | Danone Sa | Nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos. |
DE60018919T2 (de) * | 1999-05-07 | 2006-05-18 | Compagnie Gervais Danone | Verwendung von milchsaürebakterien bei der herstellung von fermentierten milchprodukten zur behandlung von verringerten immunitätsebenen |
CA2374937A1 (en) * | 1999-05-25 | 2000-11-30 | Gregor Reid | Oral administration of lactobacillus for the maintenance of health in women |
WO2000071139A2 (en) * | 1999-05-25 | 2000-11-30 | Gregor Reid | Lactobacillus compositions and methods for preventing wound infections and biofilm formation on implantable surgical devices |
US20030180260A1 (en) * | 2000-06-19 | 2003-09-25 | Clancy Robert Llewellyn | Immunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor |
ES2169675B1 (es) * | 2000-07-19 | 2003-04-16 | Danone Sa | Producto con propiedades antiinflamatorias para el colon humano. |
CA2364249A1 (fr) | 2001-11-27 | 2003-05-27 | Unknown-Inconnu | Effet de bacteries lactiques sur l'apoptose cellulaire de tumeur |
WO2003080813A2 (en) | 2002-03-21 | 2003-10-02 | Bifodan A/S | Lactobacillus strains |
CN1317385C (zh) | 2003-05-30 | 2007-05-23 | 上海光明乳业股份有限公司 | 干酪乳杆菌Bd-II菌株及其在降低血脂方面的应用 |
CA2448843A1 (fr) * | 2003-11-13 | 2005-05-13 | Bio-K Plus International Inc. | Effets de differents surnageants de bacteries lactiques de bio-k plus sur des lignees cellulaires endotheliales |
US8894991B2 (en) | 2003-12-19 | 2014-11-25 | The Iams Company | Canine probiotic Lactobacilli |
US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
US20050152884A1 (en) | 2003-12-19 | 2005-07-14 | The Procter & Gamble Company | Canine probiotic Bifidobacteria globosum |
US7785635B1 (en) | 2003-12-19 | 2010-08-31 | The Procter & Gamble Company | Methods of use of probiotic lactobacilli for companion animals |
CA2470090A1 (fr) * | 2004-06-18 | 2005-12-18 | Bio-K Plus International Inc. | Bacteries lactiques et leurs usages dans la prevention de diarrhee associee aux antibiotiques |
JP4938006B2 (ja) | 2005-05-31 | 2012-05-23 | ザ・アイムス・カンパニー | ネコ科動物プロバイオティク・ビフィドバクテリア |
EP1880001B1 (de) | 2005-05-31 | 2011-06-08 | The Iams Company | Feline probiotische lactobacilli |
US20110165127A1 (en) * | 2006-06-09 | 2011-07-07 | Fabiola Masri | Dairy-derived probiotic compositions and uses thereof |
EP2839836B2 (de) * | 2006-10-02 | 2024-06-26 | International N&H Denmark ApS | Probiotika zur Verwendung bei der Reduzierung des Auftretens und der Dauer von Krankheiten |
AU2013201783B2 (en) * | 2006-10-02 | 2015-06-04 | International N&H Denmark Aps | Probiotics for use in reducing the incidence and duration of illness |
MX2009006810A (es) * | 2006-12-22 | 2009-11-23 | Francois-Marie Luquet | Inhibicion del crecimiento de microorganismos por bacterias del acido lactico. |
WO2008077251A1 (en) * | 2006-12-22 | 2008-07-03 | Bio-K Plus International Inc. | Growth inhibition and elimination of methicillin-resistant staphylococcus aureus by lactic acid bacteria |
WO2008093303A2 (en) | 2007-02-01 | 2008-08-07 | The Iams Company | Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts |
CN101250493B (zh) * | 2008-04-01 | 2010-06-02 | 浙江省农业科学院 | 固、液二步发酵工艺生产饲用嗜酸乳杆菌的方法 |
US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
CL2009001511A1 (es) * | 2009-07-02 | 2009-10-23 | Univ De Concepcion 61 02% | Formulacion farmaceutica que comprende cepas viables de lactobacillus acidophilus lpv 31 y l. plantarum lpm-01, la cual es util en la prevencion y/o tratamiento de infecciones urinarias y en mejorar la respuesta inmune en pacientes inmunocopromentidos. |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
KR20160022909A (ko) | 2013-06-27 | 2016-03-02 | 스타벅스 코포레이션 디/비/에이 스타벅스 커피 컴퍼니 | 음료 및 다른 식품들을 위한 생물보존 방법 |
AT517321A1 (de) * | 2015-06-10 | 2016-12-15 | Trodat Gmbh | Stempel |
WO2023066973A1 (en) * | 2021-10-19 | 2023-04-27 | Kerry Group Services International Limited | Probiotic strains for reducing blood cholesterol and/or treating dyslipidemia, and methods for using and producing the same |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61109729A (ja) * | 1984-11-05 | 1986-05-28 | Advance Res & Dev Co Ltd | コレステロ−ル低下剤 |
US4839281A (en) * | 1985-04-17 | 1989-06-13 | New England Medical Center Hospitals, Inc. | Lactobacillus strains and methods of selection |
GB2261372A (en) * | 1991-11-15 | 1993-05-19 | Gregor Reid | Lactobacillus and skim milk compositions for prevention of urogenital infection |
US5716615A (en) * | 1992-02-10 | 1998-02-10 | Renata Maria Anna Cavaliere Vesely | Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use |
DE69219768T2 (de) * | 1992-07-06 | 1997-08-28 | Nestle Sa | Milchbakterien |
ATE161181T1 (de) * | 1992-07-06 | 1998-01-15 | Nestle Sa | Lactobacillus acidophilus enthaltende antigastritis-mittel |
JP2992945B2 (ja) * | 1994-03-11 | 1999-12-20 | カルピス株式会社 | ラクトバチルス・アシドフィルス乳酸菌 |
-
1997
- 1997-11-28 WO PCT/CA1997/000915 patent/WO1998023727A1/en active IP Right Grant
- 1997-11-28 ES ES97945702T patent/ES2283027T3/es not_active Expired - Lifetime
- 1997-11-28 DE DE69737420T patent/DE69737420T2/de not_active Expired - Lifetime
- 1997-11-28 AT AT97945702T patent/ATE355360T1/de not_active IP Right Cessation
- 1997-11-28 AU AU51137/98A patent/AU5113798A/en not_active Abandoned
- 1997-11-28 CA CA002271930A patent/CA2271930C/en not_active Expired - Lifetime
- 1997-11-28 EP EP97945702A patent/EP0951531B1/de not_active Expired - Lifetime
- 1997-11-28 EP EP09014543A patent/EP2159277A1/de not_active Withdrawn
-
1999
- 1999-05-28 US US09/322,030 patent/US6607905B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES2283027T3 (es) | 2007-10-16 |
EP2159277A1 (de) | 2010-03-03 |
DE69737420T2 (de) | 2007-11-15 |
EP0951531A1 (de) | 1999-10-27 |
WO1998023727A1 (en) | 1998-06-04 |
CA2271930A1 (en) | 1998-06-04 |
AU5113798A (en) | 1998-06-22 |
US6607905B1 (en) | 2003-08-19 |
CA2271930C (en) | 2006-10-17 |
DE69737420D1 (de) | 2007-04-12 |
EP0951531B1 (de) | 2007-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE355360T1 (de) | Milchsaüreferment das ein spezieller stamm von lactobacillus acidophilus enthältund verwendung | |
RU93049638A (ru) | Молочно-кислая бактерия | |
DE69224814T2 (de) | Den darm kolonisierende laktobacillen | |
DE69535290D1 (de) | Herstellung von durch streptococcus thermophilus fermentierten produkten mit hohem gehalt von galacto-oligosacchariden und beta-galactosidase | |
MXPA04000808A (es) | Cepas probioticas de lactobacillus salivarius. | |
UA42092C2 (uk) | Штам молочнокислих бактерій bifidobacterium breve, штам молочнокислих бактерій bifidobacterium infantis, штам молочнокислих бактерій bifidobacterium longum для покращення кишкової флори, спосіб покращення кишкової флори | |
NZ502610A (en) | Use of lactobacillus for reduction of the fibrinogen level in blood | |
FR12C0065I1 (de) | ||
HUT39480A (en) | Process for preparing antibiotic complex a 40926 and pure components thereof i.e. factors pa, pb, a, b and b down o | |
BR9609041A (pt) | "terapia de substituição para cáries dentais". | |
DE69030326D1 (de) | Zubereitung mit ligninabbauender aktivität, verfahren zu deren herstellung und anwendungen dafür | |
ATE299177T1 (de) | Milchsäurebakterien und ihre anwendung zur herstellung von hypercholesterolemische aktive produkte | |
EP0486024A3 (en) | Lactobacillus sp.b001 and method of producing mannitol, acetic acid and lactic acid | |
EP0486067A3 (en) | Peroxidase gene of microbial origin | |
ATE291353T1 (de) | Verwendung von milchsaürebakterien bei der herstellung von fermentierten milchprodukten zur behandlung von verringerten immunitätsebenen | |
EP0304897A3 (de) | Mittel zur Immunisierung des menschlichen Körpers bei HIV-Infektionen | |
AU3846595A (en) | Doubly virus-inactivated human blood plasma, blood plasma derivatives produced therefrom and method for their production | |
RU92015133A (ru) | Консорциум бактерий (lactobacillus salivarius var. salivaris lactobacillus acidophilus, lactobacillus lactis) 3843 для активации фотосинтеза | |
SE9201006D0 (sv) | Delignifying preparation exhibiting alpha-l-arabino -furanosidase activity, production and application thereof | |
DE69225039D1 (de) | Mikroorganismen und Verfahren zur Herstellung von 3-Alpha, 7-Alpha-Dihydroxy-12-Keto-Cholansäure |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0951531 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |